| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000043654 |
| Receipt No. | R000049673 |
| Scientific Title | Aroma therapy for females with headache |
| Date of disclosure of the study information | 2021/04/01 |
| Last modified on | 2022/09/18 (Ver. 2) |
| Basic information | ||
| Public title | Aroma therapy for females with headache | |
| Acronym | Aroma therapy for females with headache | |
| Scientific Title | Aroma therapy for females with headache | |
| Scientific Title:Acronym | Aroma therapy for females with headache | |
| Region |
|
|
| Condition | ||
| Condition | migraine, tension headache | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy of aromatherapy |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Frequency and severity of headache |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Aromatherapy | |
| Interventions/Control_2 | No treatment | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1) Diagnosed as migraine, tension headache, or both
2) Taking one or more headache medicine 3) Female 4) Age 16 or more 5) One who can provide written informed consent on her own will 6) Outpatient |
|||
| Key exclusion criteria | 1) Intracranial diseases within 3 months
2) Severe olfactory disturbance 3) Psychiatric diseases requiring medication 4) One who are already doing aromatherapy 5) Enrolled in other clinical trial for headache within 3 months 6) Uncontrolled organic disease 7) Dementia 8) One who are judged as not suitable for the study |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kurashiki Heisei Hospital | ||||||
| Division name | Department of Neurology | ||||||
| Zip code | 710-0826 | ||||||
| Address | 4-3-38 Oimatsu-cho, Kurashiki-shi, Okayama | ||||||
| TEL | 086-427-1111 | ||||||
| nozomih.24@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kurashiki Heisei Hospital | ||||||
| Division name | Medical secretary | ||||||
| Zip code | 710-0826 | ||||||
| Address | 4-3-38 Oimatsu-cho, Kurashiki-shi, Okayama | ||||||
| TEL | 086-427-1111 | ||||||
| Homepage URL | |||||||
| hisyo3@heisei.or.jp | |||||||
| Sponsor | |
| Institute | Kurashiki Heisei Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Neurology, Okayama University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kurashiki Heisei Hospital, Ethics Committee |
| Address | 4-3-38 Oimatsu-cho, Kurashiki-shi, Okayama |
| Tel | 086-427-1111 |
| hisyo3@heisei.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000049673 |